ArrowMark Colorado Holdings LLC Sells 135,035 Shares of HealthEquity, Inc. (NASDAQ:HQY)

ArrowMark Colorado Holdings LLC cut its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 12.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 985,834 shares of the company’s stock after selling 135,035 shares during the quarter. ArrowMark Colorado Holdings LLC owned approximately 1.13% of HealthEquity worth $80,691,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. International Assets Investment Management LLC purchased a new position in shares of HealthEquity during the second quarter valued at approximately $35,000. Paladin Wealth LLC bought a new position in shares of HealthEquity during the third quarter valued at $39,000. GAMMA Investing LLC increased its holdings in shares of HealthEquity by 114.8% during the second quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock valued at $51,000 after acquiring an additional 318 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of HealthEquity in the 2nd quarter worth about $73,000. Finally, 1620 Investment Advisors Inc. bought a new position in HealthEquity in the 3rd quarter worth about $112,000. 99.55% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft upped their target price on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. Barrington Research restated an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a research note on Friday, September 20th. JMP Securities reaffirmed a “market outperform” rating and set a $105.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Royal Bank of Canada reiterated an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. Finally, The Goldman Sachs Group began coverage on shares of HealthEquity in a report on Friday, November 15th. They set a “neutral” rating and a $108.00 price target on the stock. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $107.23.

HealthEquity Trading Down 0.9 %

Shares of NASDAQ:HQY opened at $101.54 on Monday. The stock has a 50 day moving average of $90.16 and a 200 day moving average of $82.85. The company has a market cap of $8.87 billion, a PE ratio of 84.62, a price-to-earnings-growth ratio of 1.59 and a beta of 0.52. HealthEquity, Inc. has a 12-month low of $62.10 and a 12-month high of $105.82. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The business had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. As a group, equities research analysts expect that HealthEquity, Inc. will post 2.27 EPS for the current year.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Frank Corvino sold 1,247 shares of the firm’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the transaction, the director now owns 4,823 shares in the company, valued at $387,093.98. This trade represents a 20.54 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 10,536 shares of company stock valued at $884,517 over the last 90 days. Company insiders own 2.20% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.